Clinical trial
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women…
NCT00287482 · Women and Infants Hospital of Rhode Island, Other · Terminated
Key facts
| NCT number | NCT00287482 |
|---|---|
| Title | Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. |
| Official title | A Pilot Study of the Herbal Remedy Essiac (ESIAK ®) Versus Placebo in Improving the Quality of Life in Women Completing Adjuvant Treatment for Breast or Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers. |
| Lead sponsor | Women and Infants Hospital of Rhode Island, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Breast Cancer |
| Intervention type | Drug |
| Interventions | Essiac |
| Enrollment | 20 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Feb 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: